15/09/2025
Let's talk about Equity Release - what is it, what can it be used for, what are the risks and benefits?
For many people in later life, their biggest asset isn’t in the bank - it’s in their bricks and mortar. Equity release (or later life lending) allows homeowners aged 55+ to access some of that value while continuing to live in their home. You can choose to make some monthly payments or none – this will have a direct impact on how much equity will remain in the property when it comes time to sell.
💡 What could it be used for?
• Boosting retirement income
• Helping children or grandchildren onto the property ladder
• Paying off existing debts
• Making home improvements or adaptations
• Funding big life plans, like travel or healthcare needs
✅ Pros:
• Access cash without selling your home
• Flexibility - lump sum, regular payments, or both
• No monthly repayments required with some plans
• You stay in your home for life (or until you move into care)
• Regulated products offer protections like a “no negative equity” guarantee
⚠️ Cons:
• Interest can roll up quickly, increasing the debt over time
• Will reduce the inheritance you leave behind
• May affect eligibility for means-tested benefits
• Early repayment charges can apply if you change your mind
• Fewer options if you want to move house later
Equity release isn’t right for everyone - but for some, it can be a useful way of reshaping wealth in retirement. Independent, regulated advice is essential before making any decisions.
Get in touch with our team of qualified equity release experts:
[email protected]
01642 134100
www.astutefin.co.uk
________________________________________
A lifetime mortgage is a loan secured against your home. You must be 55 or over to apply, and it may reduce the value of your estate and affect your entitlement to means-tested benefits. Your home may be repossessed if you do not keep up repayments on a mortgage or other debt secured against it. Astute Financial is authorised and regulated by the Financial Conduct Authority, FCA No. 811049.